IRIS
ASCARI, EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.874
EU - Europa 2.287
AS - Asia 1.695
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
AF - Africa 2
Totale 6.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.854
CN - Cina 1.503
IE - Irlanda 682
UA - Ucraina 464
FI - Finlandia 322
SE - Svezia 268
DE - Germania 248
SG - Singapore 145
GB - Regno Unito 108
IT - Italia 97
FR - Francia 43
CA - Canada 19
IN - India 19
BE - Belgio 17
IR - Iran 14
NL - Olanda 13
AU - Australia 10
RU - Federazione Russa 9
DK - Danimarca 4
EU - Europa 4
HK - Hong Kong 3
JP - Giappone 3
RO - Romania 3
BR - Brasile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IQ - Iraq 2
LT - Lituania 2
MU - Mauritius 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
ES - Italia 1
ID - Indonesia 1
JO - Giordania 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
TR - Turchia 1
VN - Vietnam 1
Totale 6.877
Salva come PNG Salva come JPEG
Città #
Dublin 681
Chandler 591
Jacksonville 570
Nanjing 452
Boardman 202
Nanchang 191
Ashburn 167
Princeton 137
Beijing 125
Hebei 125
Lawrence 125
Shenyang 124
Medford 121
Changsha 113
Wilmington 112
Jiaxing 99
Singapore 88
Helsinki 85
Ann Arbor 77
Hangzhou 70
Tianjin 70
Milan 38
Shanghai 38
Woodbridge 33
Norwalk 28
Verona 24
New York 20
Fairfield 19
Brussels 17
Toronto 17
Los Angeles 16
Seattle 15
Houston 12
Kunming 12
Jinan 10
Auburn Hills 9
Des Moines 9
Ningbo 8
Piscataway 8
San Genesio Ed Uniti 8
Taizhou 7
Falls Church 6
Guangzhou 6
Orange 6
Zhengzhou 6
Andover 5
Ardabil 5
Chicago 5
Fuzhou 5
Melbourne 5
Lanzhou 4
San Francisco 4
Munich 3
Phoenix 3
Pune 3
Rockville 3
Rome 3
Sacramento 3
Tappahannock 3
Tuglie 3
Washington 3
Arlington 2
Belo Horizonte 2
Borås 2
Brno 2
Changchun 2
Dearborn 2
Delhi 2
Leawood 2
Naples 2
New Delhi 2
Norwich 2
Pavia 2
Romainville 2
Santa Clara 2
Tokyo 2
Adelaide 1
Amman 1
Amsterdam 1
Baghdad 1
Bari 1
Bridgeport 1
Canberra 1
Charlotte 1
Cupertino 1
Dallas 1
Desenzano Del Garda 1
Dhaka 1
Edmonton 1
Elphin 1
Falkenstein 1
Frankfurt am Main 1
Groningen 1
Haikou 1
Hanoi 1
Hanover 1
Henderson 1
Hengyang 1
Inveruno 1
Karaganda 1
Totale 4.811
Salva come PNG Salva come JPEG
Nome #
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 84
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 83
Anomalous erythrocytes produced by rabbits with liver damage. 81
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 81
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 81
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 80
AMYLOIDOSIS AL 79
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 79
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 77
Acute phase proteins and prognosis in multiple myeloma. 77
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 76
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 75
Acute promyelocitic leukemia toluidine blue subtype. 74
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 72
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 72
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 72
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 71
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 70
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 70
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 69
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 69
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 68
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 68
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 67
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 67
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 67
Anemie megaloblastiche. 66
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 65
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 64
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 64
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 64
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 64
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 63
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 63
Biologia e clinica del mieloma multiplo. 63
Changing clinical presentation of multiple myeloma. 63
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 62
Glycopeptides of erythrocyte membranes in some hematological disorders 62
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 62
Acquired immune thrombastenia: a new bleeding disorder. 61
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 61
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 60
Possible evolution of human parvovirus B19 infection into erythroleukemia 60
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 60
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 60
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 60
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 59
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 59
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 59
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 58
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 57
Applicazioni cliniche dei fattori di crescita emopoietici. 56
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 56
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 55
Silymarine during maintenance therapy of acute promyelocytic leukemia. 55
Applicazioni cliniche della citometria. 55
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 54
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 54
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 54
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 53
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 53
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 53
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 53
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 53
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 52
Acute promyelocytic leukemia: morphological and clinical features. 52
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 52
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 52
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 52
Terapia del mieloma multiplo. 51
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 51
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 51
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 51
Fisiopatologia dell'eritrocito. 50
New approaches to cancer chemotherapy. 49
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 49
IL MIELOMA MULTIPLO 49
Cytokinetic studies on circulating neoplastic cells of Hodgkin's disease. 49
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 49
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 49
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 48
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 48
Chemotherapy-induced leukonychia 48
Multilineage dysplasia without increased blasts identifies a poor prognosis subset of myelodysplastic syndromes. 47
Il trattamento del carcinoma mammario. 47
Oral idarubicin and prednisone for advanced, previously untreated multiple myeloma: a pilot study. 47
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes 47
Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma 46
Erythrocyte membrane modifications in chronic granulocytic leukaemia 46
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 46
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 46
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 46
Post remission chemotherapy in adult non lymphoblastic leukemia: results of two protocols including intensive or non-intensive consolidation therapy. 46
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 45
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 45
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 45
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 45
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 45
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 45
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 44
Totale 5.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020338 0 0 0 0 0 0 14 95 6 159 64 0
2020/2021875 92 71 32 84 7 129 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/2025350 44 142 37 52 25 49 1 0 0 0 0 0
Totale 6.951